FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tiffany Traina

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Axilla

Co-author Network

Publications

TOP 3
Alice Ho; Clifford A Hudis; Tari A King; Beryl Mc Cormick; Monica Morrow; Sujata M Patil; Carmen A Perez; Simon N Powell; Edi Brogi; Gaorav Gupta; Katherine H Rogers; Tiffany A Traina; Yong Hannah Wen; Mark Robson
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
Ayca Gucalp; Clifford Hudis; Joan Massague; Larry Norton; Sujata Patil; Christine Pellegrino; Jean Santamauro; Joseph A Sparano; Maria Theodoulou-Haber; Alyson Abbruzzi; Jackie Bromberg; James Caravelli; Chau Dang; Tiffany A Traina
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Devika Gajria; Stephanie Geneus; Clifford A Hudis; Larry Norton; Sujata Patil; Lee K Tan; Maria Theodoulou-Haber; Kimberly Feigin; Tiffany A Traina
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tiffany Traina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alice Ho; Clifford A Hudis; Tari A King; Beryl Mc Cormick; Monica Morrow; Sujata M Patil; Carmen A Perez; Simon N Powell; Edi Brogi; Gaorav Gupta; Katherine H Rogers; Tiffany A Traina; Yong Hannah Wen; Mark Robson
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy.
Cancer 2012;118(20):4944-52.
2011: Ayca Gucalp; Clifford Hudis; Joan Massague; Larry Norton; Sujata Patil; Christine Pellegrino; Jean Santamauro; Joseph A Sparano; Maria Theodoulou-Haber; Alyson Abbruzzi; Jackie Bromberg; James Caravelli; Chau Dang; Tiffany A Traina
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Clinical breast cancer 2011;11(5):306-11.
2011: Devika Gajria; Stephanie Geneus; Clifford A Hudis; Larry Norton; Sujata Patil; Lee K Tan; Maria Theodoulou-Haber; Kimberly Feigin; Tiffany A Traina
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.
Cancer 2011;117(18):4125-31.
2011: Amer Karam; Monica Morrow; Sujata Patil; Michelle Stempel; Tiffany A Traina; Hiram S Cody; Alice Ho; Meier Hsu; Mary L Gemignani
Determinants of outcome in elderly patients with positive sentinel lymph nodes.
American journal of surgery 2011;201(6):734-40.
2011: Ayca Gucalp; Tiffany A Traina
Triple-negative breast cancer: adjuvant therapeutic options.
Chemotherapy research and practice 2011;2011():696208.
2010: Clifford Hudis; Tiffany A Traina; Larry Norton
Capecitabine dosing is not yet optimized for breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2291; author reply 2291-2.
2010: Matthew Pugliese; Michelle Stempel; Sujata M Patil; Meier Hsu; Alice Ho; Tiffany A Traina; Monica Morrow; Hiram S Cody; Mary L Gemignani
The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer.
American journal of surgery 2010;200(3):368-73.
2010: Alison K Conlin; Andrew D Seidman; Ariadne M Bach; Diana Lake; Maura Dickler; Gabriella D'Andrea-Carlino; Tiffany A Traina; Michael Danso; Adam M Brufsky; Mansoor Saleh; Alicia Clawson; Clifford Hudis
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
Clinical breast cancer 2010;10(4):281-7.
2010: Matthew S Pugliese; Amer Karam; Meier Hsu; Michelle M Stempel; Sujata M Patil; Alice Ho; Tiffany A Traina; Kimberly Van Zee; Hiram S Cody; Monica Morrow; Mary L Gemignani
Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Annals of surgical oncology 2010;17(4):1063-8.
2010: Tiffany A Traina; Hope S Rugo; James Caravelli; Sujata M Patil; Benjamin Yeh; Michele E Melisko; John W Park; Stephanie Geneus; Matthew Paulson; Jill Grothusen; Andrew D Seidman; Monica Fornier; Diana E Lake; Chau Dang; Mark Robson; Maria Theodoulou-Haber; Carlos D Flombaum; Larry Norton; Clifford Hudis; Maura Dickler
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):628-33.
2010: Tiffany A Traina; Ute Dugan; Brian Higgins; Kenneth Kolinsky; Maria Theodoulou-Haber; Clifford A Hudis; Larry Norton
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.
Breast disease 2010;31(1):7-18.
2010: Ayca Gucalp; Tiffany A Traina
Triple-negative breast cancer: role of the androgen receptor.
Cancer journal (Sudbury, Mass.) 2010;16(1):62-5.
2010: Shari Goldfarb; Tiffany A Traina; Maura Dickler
Bevacizumab for advanced breast cancer.
Women's health (London, England) 2010;6(1):17-25.
2009: Patrick G Morris; Maura Dickler; Heather L McArthur; Tiffany A Traina; Steven Sugarman; Nancy Lin; Beverly Moy; Steven Come; Laura Godfrey; Benjamin Nulsen; Carol Chen; Richard M Steingart; Hope S Rugo; Larry Norton; Eric Winer; Clifford Hudis; Chau Dang
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6117-23.
2009: Francesco Atzori; Tiffany A Traina; Maria Teresa Ionta; Bruno Massidda
Targeting insulin-like growth factor type 1 receptor in cancer therapy.
Targeted oncology 2009;4(4):255-66.
2009: Kevin Kalinsky; Lindsay M Jacks; Adriana Heguy; Sujata M Patil; Marija Drobnjak; Umeshkumar K Bhanot; Cyrus V Hedvat; Tiffany A Traina; David B Solit; William Gerald; Mary Ellen Moynahan
PIK3CA mutation associates with improved outcome in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5049-59.
2009: Amer Karam; Meier Hsu; Sujata M Patil; Michelle Stempel; Tiffany A Traina; Alice Ho; Hiram S Cody; Elisa Rush Port; Monica Morrow; Mary L Gemignani
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.
Annals of surgical oncology 2009;16(7):1952-8.
2009: Tiffany A Traina
Bevacizumab in the treatment of metastatic breast cancer.
Oncology (Williston Park, N.Y.) 2009;23(4):327-32.
2009: Ana M Gonzalez-Angulo; Katherine Stemke-Hale; Shana L Palla; Mark Carey; Roshan Agarwal; Funda Meric-Berstam; Tiffany A Traina; Clifford Hudis; Gabriel N Hortobagyi; William L Gerald; Gordon B Mills; Bryan T. J. Hennessy
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2472-8.
2008: Tiffany A Traina; Italo POggesi; Mark Robson; A Asnis; B A Duncan; Alexandra S Heerdt; Chau Dang; Diana E Lake; Mark M Moasser; Katherine S Panageas; Patrick I Borgen; Larry Norton; Clifford Hudis; Maura Dickler
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.
Breast cancer research and treatment 2008;111(2):377-88.
2008: Tiffany A Traina; Maria Theodoulou-Haber; Kimberly Feigin; Sujata M Patil; K Lee Tan; Charles Edwards; Ute Dugan; Larry Norton; Clifford Hudis
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1797-802.
2008: Robert W Carlson; Susan Moench; Arti Hurria; Lodovico Balducci; Harold J Burstein; Lori J Goldstein; William J Gradishar; Kevin S Hughes; Mohammad Jahanzeb; Stuart M Lichtman; Lawrence Marks; Joan S McClure; Beryl Mc Cormick; Lisle M Nabell; Lori J Pierce; Mary Lou Smith; Neal S Topham; Tiffany A Traina; John H Ward; Eric P Winer
NCCN Task Force Report: breast cancer in the older woman.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 4():S1-25; quiz S26-7.
2007: Tiffany A Traina; Hope S Rugo; Maura Dickler
Bevacizumab for advanced breast cancer.
Hematology/oncology clinics of North America 2007;21(2):303-19.
2006: Tiffany A Traina; Larry Norton; Karen Drucker; Bhuvanesh Singh
Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer.
The oncologist 2006;11(10):1070-1.
2005: Tiffany A Traina; Gregory D Leonard; Laura H Tang; Philip B Paty; ROBERT G MAKI
Metastatic colon cancer to the ovaries in a Krukenberg-like pattern.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5255-6.
2004: Tiffany A Traina; Paul Sabbatini; Carol Aghajanian; Jakob Dupont
Weekly topotecan for recurrent endometrial cancer: a case series and review of the literature.
Gynecologic oncology 2004;95(1):235-41.
2004: Tiffany A Traina; Maura Dickler
Aromatase inhibitors for hormonal therapy of early-stage breast cancer.
Current opinion in investigational drugs (London, England : 2000) 2004;5(6):605-10.